Building a CLL Game Plan
Strategies for Treatment, Trials, and Team Building
Wednesday, Oct. 8, 2025 at 3pm PT / 6pm ET
Chronic lymphocytic leukemia (CLL) care is more personalized than ever.
CLL patient advocate Jeff Folloder and expert hematologist-oncologist Dr. Nicole Lamanna (Columbia University Irving Medical Center) explain how today’s innovative targeted therapies, time-limited treatment options, and emerging clinical trials can help patients craft a care strategy that truly fits their needs. The conversation dives into how to assemble a strong, collaborative medical team, at both local hospitals and major centers, so patients and families feel empowered at every step.
Program Topics
- Set Your Treatment Strategy: Understand targeted therapies (BTK and BCL-2 inhibitors), their benefits, and when time-limited options fit your journey
- Explore Clinical Trials: Discover how and where clinical trials fit in the CLL landscape, plus how to find the right match—whether at a major center or community clinic
- Build an Empowered Team: Learn how to connect with local doctors and specialists from top centers for a coordinated plan, and what roles nurses, advocates, and social workers play
- Get Organized: Practical tips for tracking labs, sharing results, and communicating with your care team
- Prioritize Quality of Life: Find resources to manage daily challenges like fatigue, infection risk, and stress, while keeping your goals central to treatment talks
- Join Your CLL Community: How support groups and partnerships can boost health literacy, advocacy, and your decision-making power
We would like to thank Blood Cancer United and the CLL Society for their partnerships.
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider for treatment decisions.
Thank you to AbbVie for its support of our independent patient education program. The Patient Story retains full editorial control over all content.
